Functional Technologies Corp. (TSX VENTURE:FEB), a world leader in yeast research and development, announced today that it has developed, tested and filed patent applications for yeast technology that reduces the formation of acrylamide, a carcinogen formed when starchy foods are baked, fried or toasted. Recognized globally as a serious food safety issue since 2002, acrylamide has been found in many widely consumed foods, including bread, cookies, crackers, baby food, breakfast cereal, French fries and potato chips...
Arcadia Biosciences, Inc., an agricultural technology company focused on developing technologies and products that benefit the environment and human health, announced today that it has successfully completed the first commercial production of SONOVA™ 400 High GLA Safflower Oil. Seed produced by the first High GLA Safflower crop, grown during 2009, was processed to produce commercial quantities of SONOVA™ 400 oil, which is now available for distribution as a key ingredient in dietary supplements...
Orthopaedic surgeon Kevin P. Black, MD, of Hershey, Penn., was elected to the Board of Directors of the American Academy of Orthopaedic Surgeons (AAOS) at the organization's 2010 Annual Meeting in New Orleans. "It's an enormous honor to be elected to the AAOS Board of Directors," said Dr. Black. "I'm looking forward to working with and learning from the other members of the Board and having the opportunity to contribute to our great profession and ultimately the patients for whom we care." Dr...
Title: Intense Cholesterol, Blood Pressure Therapies Don't Help Type 2 Diabetics Category: Health News Created: 3/14/2010 10:10:00 AM Last Editorial Review: 3/15/2010